The dysfunction of hematopoietic stem and progenitor cells drives inflammation-related myelopoiesis, which maintains neutrophil populations and promotes chronic inflammation [126]
Persistent severe symptoms warrant clinical review, as 3.9% of participants discontinued therapy due to GI intolerance, especially if fluid loss led to dehydration
Typically, this means the cases share a common defendant, a common product, and substantially similar allegations
Improving insulin sensitivity can have downstream effects on other hormonal systems
The difference lies in the dosage and approval: Wegovy uses a higher dose (up to 2.4 mg per week) and has been approved for people with: A BMI of 30 or higher, or A BMI of 27+ with a related health condition (such as high blood pressure or type 2 diabetes) Because of its targeted purpose, Wegovy is often the better option for patients focused solely on weight loss in Ontario especially when paired with nutritional and behavioural support
contributed to this report.